GRANULES INDIA LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 398 INR | +1.53% |
|
-5.98% | -1.81% |
| 04-30 | Granules Pharmaceuticals Arm Gets US FDA's Approval for Generic Drug for Gout Flares | MT |
| 04-15 | Granules India Gets Zero Observation from US FDA After Inspection of Visakhapatnam, India Unit | MT |
Evolution of the average Target Price on Granules India Limited
Price target over the last 5 years
History of analyst recommendation changes
a9e29ade7733355a7c1d6.lG9KZc6MAuqxC71F_uWHqw2jgWCp1SaarJuDPtOgZaY.wV4ZPYDqeJjQON5yzNPv_WKO8y2ehGGuysTrSOPSVfSmXQUp_NVHjdd4_A~23f2ace2a214df5a4f7287c8d7a39d99
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
398
INR
Average target price
483.4
INR
Spread / Average Target
+21.45%
High Price Target
515
INR
Spread / Highest target
+29.38%
Low Price Target
455
INR
Spread / Lowest Target
+14.31%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
C-
EPS Revisions
- Stock Market
- Equities
- GRANULES Stock
- Consensus Granules India Limited